These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3433308)

  • 41. Experimental plague in the California ground squirrel.
    Williams JE; Moussa MA; Cavanaugh DC
    J Infect Dis; 1979 Oct; 140(4):618-21. PubMed ID: 512421
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.
    Philipovskiy AV; Smiley ST
    Infect Immun; 2007 Feb; 75(2):878-85. PubMed ID: 17118978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague.
    Welkos S; Pitt ML; Martinez M; Friedlander A; Vogel P; Tammariello R
    Vaccine; 2002 May; 20(17-18):2206-14. PubMed ID: 12009274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Dynamics of F1 antibody responses to
    Meng WW; ; Wang XH; ; ; Luo T; Li B; ; Wang QG; Guo R; Dai X; Zhang YJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):353-357. PubMed ID: 28395471
    [No Abstract]   [Full Text] [Related]  

  • 45. Studies on the role of plasminogen activator in systemic infection by virulent Yersinia pestis strain C092.
    Welkos SL; Friedlander AM; Davis KJ
    Microb Pathog; 1997 Oct; 23(4):211-23. PubMed ID: 9344782
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic infections in laboratory rodents from inoculation of nonencapsulated plague bacilli (Yersinia pestis).
    Williams JE; Cavanaugh DC
    Experientia; 1983 Apr; 39(4):408-9. PubMed ID: 6832323
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Isolation and certain properties of the dermonecrotic toxin from Pasteurella multocida].
    Kalmykova LI; Ezepchuk IuV; Shegidevich EA; Navasardiants DG
    Mol Gen Mikrobiol Virusol; 1991 Aug; (8):29-32. PubMed ID: 1784303
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunogenicity and efficacy of an anthrax/plague DNA fusion vaccine in a mouse model.
    Albrecht MT; Eyles JE; Baillie LW; Keane-Myers AM
    FEMS Immunol Med Microbiol; 2012 Aug; 65(3):505-9. PubMed ID: 22515653
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on plague. I. Purification and properties of the toxin of Pasteurella pestis.
    AJL SJ; REEDAL JS; DURRUM EL; WARREN J
    J Bacteriol; 1955 Aug; 70(2):158-69. PubMed ID: 13251981
    [No Abstract]   [Full Text] [Related]  

  • 50. Application of r-PFE hyperimmune sera for concurrent detection of Bacillus anthracis, Yersinia pestis and staphylococcal enterotoxin B.
    Balakrishna K; Tuteja U; Murali HS; Batra HV
    J Appl Microbiol; 2014 Jun; 116(6):1465-73. PubMed ID: 24905217
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunity in plague: protection of the vervet (Cercopithecus aethips) against pneumonic plague by the oral administration of live attenuated Yersinia pestis.
    Chen TH; Elberg SS; Eisler DM
    J Infect Dis; 1977 Feb; 135(2):289-93. PubMed ID: 402428
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plague detection by anti-carbohydrate antibodies.
    Anish C; Guo X; Wahlbrink A; Seeberger PH
    Angew Chem Int Ed Engl; 2013 Sep; 52(36):9524-8. PubMed ID: 23843253
    [No Abstract]   [Full Text] [Related]  

  • 53. The Yfe system of Yersinia pestis transports iron and manganese and is required for full virulence of plague.
    Bearden SW; Perry RD
    Mol Microbiol; 1999 Apr; 32(2):403-14. PubMed ID: 10231495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of outer membrane proteins of Yersinia pestis and Yersinia pseudotuberculosis strains isolated from India.
    Khushiramani R; Tuteja U; Shukla J; Batra HV
    Indian J Exp Biol; 2004 May; 42(5):508-14. PubMed ID: 15233478
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral vaccination against plague using Yersinia pseudotuberculosis.
    Demeure CE; Derbise A; Carniel E
    Chem Biol Interact; 2017 Apr; 267():89-95. PubMed ID: 27046452
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antigenic profiling of yersinia pestis infection in the Wyoming coyote (Canis latrans).
    Vernati G; Edwards WH; Rocke TE; Little SF; Andrews GP
    J Wildl Dis; 2011 Jan; 47(1):21-9. PubMed ID: 21269993
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague.
    Swietnicki W; Powell BS; Goodin J
    Protein Expr Purif; 2005 Jul; 42(1):166-72. PubMed ID: 15939303
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studies on plague. II. Immunological properties of purified Pasteurella pestis toxin.
    WARREN J; WALZ U; REEDAL JS; AJL SJ
    J Bacteriol; 1955 Aug; 70(2):170-6. PubMed ID: 13251982
    [No Abstract]   [Full Text] [Related]  

  • 59. [Cyclic nucleotides in the dynamic development of shock caused by the murine toxin of Yersinia pestis].
    Cherkasova TD; Vengrov PR; Melikhov VI; Avrorov VP; Iurkiv VA
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jul; (7):70-4. PubMed ID: 2823509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ACTION OF PLAGUE MURINE TOXIN ON MITOCHONDRIA FROM RESISTANT AND SUSCEPTIBLE ANIMALS.
    KADIS S; AJL SJ; RUST JH
    J Bacteriol; 1963 Oct; 86(4):757-65. PubMed ID: 14066472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.